NLRP3 and coronary artery disorder: Furthermore, rs10754555 carriers were characterized by a higher prevalence of CAD and greater incident mortality at follow-up, which was affected by NLRP3 inflammasome inducers such as urate, triglycerides, and apolipoprotein C3.